🔎 Trials Near Me

Home › Kanser sa Dugo › Tennessee

Pag-aaral pangklinika para sa Kanser sa Dugo sa Tennessee

20 pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa mga site sa Tennessee.

Mga Lungsod sa Tennessee

Opisyal na teksto ng pag-aaral (English)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

  • Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville
  • Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0015), Nashville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03486873

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

  • Sarah Cannon Cancer Institute, Nashville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07572006

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 12, Nashville
Nagre-recruitPhase 3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07504458

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • Scri Oncology Partners, Nashville
  • Vanderbilt Medical Center, Nashville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07195916

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

  • St. Jude Children's Research Hospital, Memphis
Nagre-recruitPhase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07257419

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • Baptist Clinical Research Institute, Memphis
  • Tennessee Oncology, Nashville
  • TriStar Centennial Medical Center, Nashville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • Vanderbilt University Medical Center, Nashville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

  • Sarah Cannon Research Institute - Oncology Partners, Nashville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06823167

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • Vanderbilt University, Ingram Cancer Center, Nashville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • St. Jude Childrens Research Hospital, Memphis
  • Vanderbilt University, Nashville
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

  • St. Jude Children's Research Hospital, Memphis
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 30 · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT06579469

Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products

  • St. Jude Children's Research Hospital, Memphis
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT05713214

Response to Influenza Vaccination in Pediatric Oncology Patients

  • St. Jude Children's Research Hospital, Memphis
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 18 · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT05384288

TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies

  • St. Jude Children's Research Hospital, Memphis
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Hanggang edad 21 · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT07052370

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

  • The Children's Hospital at TriStar Centennial, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
Nagre-recruitPhase 3
Edad 2 hanggang 18 · Lahat ng kasarian · Na-update May 5, 2026 · NCT05711667

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

  • TriStar Bone Marrow Transplant, Nashville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

  • St. Jude Children's Research Hospital, Memphis
Nagre-recruitPhase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT06326463

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

  • SCRI Oncology Partners, Nashville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2025 · NCT06119685

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • St. Jude Children's Research Hospital, Memphis
Nagre-recruitPhase 1
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • TriStar Bone Marrow Transplant, Nashville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.